5-acetyl-4-methyl-2-(m-chlorophenylamino)thiazole | 1019657-23-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 5-acetyl-4-methyl-2-(m-chlorophenylamino)thiazole
• 英文别名: 1-(2-(3-chlorophenylamino)-4-methylthiazol-5-yl)ethanone；1-[2-(3-Chloroanilino)-4-methyl-1,3-thiazol-5-yl]ethanone
• CAS: 1019657-23-8
• 化学式: C₁₂H₁₁ClN₂OS
• 分子量: 266.751
• InChiKey: CXSZWJZVOVWEKH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  70.2
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  5-acetyl-4-methyl-2-(m-chlorophenylamino)thiazole 在 盐酸 作用下， 以 水 、 异丙醇 为溶剂， 反应 18.75h， 生成 N’-(1-{2-[(3-chlorophenyl)amino]-4-methylthiazol-5-yl}ethylidene)morpholine-4-carbothiohydrazide
  参考文献：
  名称：

  微波辐射下5-乙酰基-2-芳氨基-4-甲基噻唑缩氨基硫脲的合成及其体外抗癌活性

  摘要：

  通过吗啉、哌嗪或 N-(4-甲氧基苯基)哌嗪与 7 种 5-乙酰基-2-芳氨基-4-甲基噻唑的甲基肼-碳二硫代酯衍生物缩合反应，制备了一系列 21 种新型三环和四环缩氨基硫脲衍生物在微波照射下。测试了所有化合物对人胃癌、肺癌和乳腺癌细胞系的体外细胞毒活性。结果表明，一些化合物显示出中等的抗癌活性。最有效的化合物是吗啉取代的类似物，对人类乳腺癌细胞表现出显着的活性。

  DOI：

  10.3184/174751916x14519928918516
• 作为产物：
  描述：

  1-(3-氯苯基)-2-硫脲 、 乙酰丙酮 在 erythrosine B 、 氧气 作用下， 以 乙腈 为溶剂， 反应 16.0h， 以55%的产率得到5-acetyl-4-methyl-2-(m-chlorophenylamino)thiazole
  参考文献：
  名称：

  硫脲和1,3-二羰基化合物的可见光介导偶联：迈向无离去合成氨基噻唑

  摘要：

  已经开发了由各种1,3-二羰基和硫脲合成的不带离去基团的氨基噻唑的方法。该反应被有机染料四碘荧光素光催化。在绿色LED照射下，硫脲原位产生硫自由基，然后添加到烯醇互变异构体中，形成氨基噻唑骨架。这种新颖的策略提供了卓越的原子经济性，从而可以替代传统的离去基团方案，从而提供了更绿色的选择。

  DOI：

  10.1002/adsc.201701565

文献信息

• Study on condensation of N-aryl thioureas with 3-bromo-acetylacetone: Synthesis of aminothiazoles and iminodihydrothiazoles, and their in vitro antiproliferative activity on human cervical cancer cells
  作者：Hai-Bo Shi、Shi-Jie Zhang、Yan-Fang Lin、Wei-Xiao Hu、Chao-Ming Cai

  DOI：10.1002/jhet.602

  日期：2011.9

  The condensation of N‐aryl thioureas with 3‐bromo‐acetylacetone in neutral solvent acetone not only led to 5‐acetyl‐4‐methyl‐2‐(substituted anilino) thiazoles 3 but also 2‐imino‐3‐(substituted phenyl)‐4‐methyl‐5‐acetyl‐2,3‐dihydrothiazoles 4. Further study found that different reaction solvents displayed an important role toward the ratio of aminothiazoles 3 and iminodihydrothiazoles 4, and the reaction

  的缩合ñ -芳基与3-溴乙酰丙酮硫脲在中性溶剂丙酮不仅导致5-乙酰基-4-甲基-2-（取代的苯胺基）噻唑类3也2-亚氨基-3-（取代苯基） - 4-甲基-5-乙酰基-2,3-二氢噻唑4。进一步的研究发现，不同的反应溶剂对氨基噻唑3和亚氨基二氢噻唑4的比例具有重要作用，并且扩大了反应范围。提出了一种可能的机制，其中涉及溶剂效应和原位氢溴酸催化。一些选定的异构体在体外表现出中等水平对人类宫颈癌细胞系的抗增殖活性（Hela，Siha）。J.杂环化​​学。（2011）。
• Synthesis and anticancer evaluation of thiazolyl–chalcones
  作者：Hai-Bo Shi、Shi-Jie Zhang、Qiu-Fu Ge、Dian-Wu Guo、Chao-Ming Cai、Wei-Xiao Hu

  DOI：10.1016/j.bmcl.2010.09.041

  日期：2010.11

  Thirty-seven (E)-1-(4-methyl-2-arylaminothiazol-5-yl)-3-arylprop-2-en-1-ones were synthesized via Claisen-Schmidt condensation of 1-(4-methyl-2-(arylamino)thiazol-5-yl) ethanone with the corresponding arylaldehydes. All these thiazolyl-chalcones were characterized and evaluated by MTT assay on human cancer cell lines BGC-823, PC-3, NCI-H460, BEL-7402 in vitro. Compounds 5, 8, 26, 37 and 41 are effective against cancer cell lines with IC(50)s below 10 mu M. The antitumor activity in ICR mice bearing sarcoma 180 tumors indicates compounds 10 and 41 have moderate in vivo activity with 22-25% tumor-weight inhibition. (C) 2010 Elsevier Ltd. All rights reserved.
• Thiazole fused thiosemicarbazones: Microwave-assisted synthesis, biological evaluation and molecular docking study
  作者：Neelam P. Prajapati、Kinjal D. Patel、Rajesh H. Vekariya、Hitesh D. Patel、Dhanaji P. Rajani

  DOI：10.1016/j.molstruc.2018.11.025

  日期：2019.3

  In the present study, series of novel compounds (E)-2-(1-(4-methyl-2-(substituted-phenylamino)thiazol-5-yl)ethylidene)hydrazinecarbothio-amide (5a-j) and (E)-N-cyclohexyl-2-(1-(4-methyl-2-(substituted-phenylamino)thiazol-5-yl)ethylidene)hydrazinecarbothioamide (6a-j) have been synthesized using microwave irradiation method in high yields and characterized by IR, H-1 NMR, C-13 NMR and mass spectral analysis. Synthesized compounds were evaluated for their in-vitro antimicrobial, antimalarial and anti-tuberculosis activity as well as in-silico study. The obtained results indicate that compound 6b and 6g were found to be the most potent against S. aureus bacterial strain. Further, the molecular docking study has been performed for all the new compounds with the immune system of S. aureus (PDB ID: 5D1Q) as a target enzyme, and this study validated the experimental results. (C) 2018 Elsevier B.V. All rights reserved.